跳至主要内容
临床试验/NCT00973856
NCT00973856已完成不适用

Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands

Cleveland Clinic Akron General1 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2009年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
5
试验地点
1
主要终点
Difference in % Reduction in Wart Size Between Product A and Product B at Each Timepoint

研究概览

简要总结

The objective is to conduct a pilot study to determine the effectiveness of PURELL VF481 to treat warts located on the hands.

详细描述

  • At least 5, but not more than 20 participants will be enrolled in the study.
  • Each wart is randomly assigned a test product prior to the start of the study
  • Warts are equally distributed between products so that an equal number of warts treated on each person. One (1) product will be assigned to each hand to minimize treatment confusion for the participants
  • The test product will be applied to a wooden applicator and gently rubbed into the wart, then covered with a latex free adhesive bandage.
  • Subjects will log date and time of application and anything notable (such as changes in wart appearance or missed dose) in a log book.
  • Measurement of wart (longest diameter) and photos taken at each visit by trained office medical assistants, LPNs, PA-C or MD.
  • Time points for office visitation: Baseline (0 weeks), 4 weeks, 8 weeks, 12 weeks

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with 2+ warts being seen at a Dermatologist's office
  • •2 or more warts on the hands that are located at least 1 cm apart or on separate fingers
  • •Warts must have been present for at least 2 months
  • •Wart size must be between 2 mm-15 mm in diameter
  • •Participants must be in good general health
  • •Participants must be able to speak and read in English.
  • •Participant must be able to read and sign participant instruction sheet, and informed consent and authorization.
  • •Subjects must be able to understand and execute the instructions presented in pictorial form.

排除标准

  • •Pregnancy (Patients will be asked to verify using criteria of contraception, menstrual cycle, and pregnancy test, if necessary).
  • •Treatment of warts with other methods such as salicylic acid, etc., in the past 14 days.
  • •Known allergies to common topical antimicrobials or the individual ingredients in either test product.
  • •Participation in a clinical study in the past 7 days or participation in another clinical study
  • •Unwillingness to perform requirements of the study
  • •Any medical condition that should preclude participation in the study, at the discretion of the physician
  • •Missed ≥ 6 of the treatments in a 4 week study period

研究组 & 干预措施

PURELL Left Hand/ Placebo Right Hand

Experimental

One product will be assigned to each hand to minimize treatment confusion for the participants.

PURELL VF481 Left Hand/ Placebo Right Hand

干预措施: PURELL VF481 (Other)

PURELL Left Hand/ Placebo Right Hand

Experimental

One product will be assigned to each hand to minimize treatment confusion for the participants.

PURELL VF481 Left Hand/ Placebo Right Hand

干预措施: Placebo Solution (Other)

Placebo Solution Left Hand/ PURELL Right hand

Placebo Comparator

One (1) product will be assigned to each hand to minimize treatment confusion for the participants PURELL VF481 Right Hand/ Placebo Left Hand

One (1) pump of test product (approximately 1.5ml) is applied to a wooden applicator and gently rubbed into the wart, then covered with a latex free adhesive bandage (it is not necessary to wait until dry) each night before bed

干预措施: PURELL VF481 (Other)

Placebo Solution Left Hand/ PURELL Right hand

Placebo Comparator

One (1) product will be assigned to each hand to minimize treatment confusion for the participants PURELL VF481 Right Hand/ Placebo Left Hand

One (1) pump of test product (approximately 1.5ml) is applied to a wooden applicator and gently rubbed into the wart, then covered with a latex free adhesive bandage (it is not necessary to wait until dry) each night before bed

干预措施: Placebo Solution (Other)

结局指标

主要结局

Difference in % Reduction in Wart Size Between Product A and Product B at Each Timepoint

时间窗: Baseline, 4, 8, and 12 weeks, change at 12 weeks reported

Data is not available due to study closure and data destruction

次要结局

  • Change in Size of Warts Treated by Each Product at Each Time Point.(Baseline, 4, 8 and 12 weeks, change at 12 weeks reported)

研究者

发起方
Cleveland Clinic Akron General
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验